In Europe was the Russian test for detection of coronavirus

Company “Testgen” received the European certificate of conformity CE for a set of reagents for the qualitative detection of RNA of coronavirus (SARS-CoV-2) by RT-PCR technique in real time “CoV-2-Test.”The existence of this document confirms compliance of a medical device company meet the requirements of the European Union.

Earlier, on 15 may, the company received a registration certificate of Roszdravnadzor and started mass production test systems. Test to determine the presence of coronavirus in a sample taken from the mucous membrane, naso – or oropharynx, with an accuracy of more than 96% in the early stages of infection.

“Our production capacities allow to produce up to 50 thousand tests a day, and in the future – up to two million per month. I am confident that our company will contribute to the fight against the pandemic, offering the world community, along with existing analogues, high-quality precision diagnostic set,” – said General Director of “Testgen” Andrew Toropovskiy.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

“Nanolek” released the first batch of hydroxychloroquine

The company “Nanolek” factory in the Kirov region has established the production of one of the drugs for the treatment of coronavirus infection of hydroxychloroquine. Currently, hydroxychloroquine is included in the treatment protocols in the interim Ministry of health recommendations for the prevention, diagnosis and treatment of new coronavirus infection. The first batch of this […]

Igor Ghahramanyan was returned to the Ministry of health

Senator Igor Ghahramanyan was appointed first Deputy Minister of health of the Russian Federation. In the Federation Council Ghahramanyan presented the Executive authority of the Yaroslavl region and held the position of first Deputy Chairman of Committee on social policy, writes “Kommersant”. From 2012 to 2017 Igor Ghahramanyan was already a Deputy and first Deputy […]

AstraZeneca localized in Russia production of ticagrelor

Company AstraZeneca localized at its own plant in Kaluga region manufacture of the finished dosage form of ticagrelor 90 mg for the treatment of patients with acute coronary syndrome (ACS). Ticagrelor (trade name of Brilinta) is included in the list of essential drugs and included in the standards of specialized medical care for patients with […]